InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

4D Molecular Therapeutics, Inc.

FDMT Clue Score62
United States Fiscal year ends December CIK 0001650648 Results filed 13 Aug 2026
Add to watchlist

What the insiders did Scheduled selling only

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
Scott Bizily
16 Oct 2026
Chief Legal Officer
Sold after exercise
1,635
$12.84
$20.99K
David Kirn
5 Oct 2026
See Remarks
Sold on a plan
272
$13.61
$3.70K
David Kirn
5 Oct 2026
See Remarks
Sold on a plan
58,061
$12.92
$750.24K
Scott Bizily
16 Sep 2026
Chief Legal Officer
Sold after exercise
1,635
$13.65
$22.32K
David Kirn
14 Sep 2026
See Remarks
Sold on a plan
58,333
$13.90
$811.00K
Scott Bizily
1 Sep 2026
Chief Legal Officer
Sold after exercise
584
$14.00
$8.18K
David Kirn
19 Aug 2026
See Remarks
Sold after exercise
25,927
$16.42
$425.65K
David Kirn
19 Aug 2026
See Remarks
Sold after exercise
43,149
$15.36
$662.62K
Scott Bizily
17 Aug 2026
Chief Legal Officer
Sold after exercise
1,635
$12.20
$19.95K
Scott Bizily
13 Aug 2026
Chief Legal Officer
Sold after exercise
1,635
$12.00
$19.62K
David Kirn
4 Aug 2026
See Remarks
Sold on a plan
26,842
$10.23
$274.60K
David Kirn
3 Aug 2026
See Remarks
Sold on a plan
12,415
$10.05
$124.72K
David Kirn
10 Jul 2026
See Remarks
Sold on a plan
442
$12.84
$5.67K
David Kirn
10 Jul 2026
See Remarks
Sold on a plan
15,283
$12.01
$183.56K
David Kirn
9 Jul 2026
See Remarks
Sold on a plan
42,608
$12.87
$548.18K
Scott Bizily
30 Jun 2026
Chief Legal Officer
Sold after exercise
6,566
$14.00
$91.92K
Scott Bizily
23 Jun 2026
Chief Legal Officer
Sold after exercise
9,810
$12.00
$117.72K
David Kirn
22 Jun 2026
See Remarks
Sold on a plan
114,746
$10.47
$1.20M
David Kirn
1 Jun 2026
See Remarks
Sold on a plan
1,922
$10.02
$19.26K
Ashoo Gupta
20 Mar 2026
VP, Finance and Controller
Sold after exercise
80
$8.61
$688.80
Ashoo Gupta
20 Mar 2026
VP, Finance and Controller
Sold after exercise
310
$8.61
$2.67K
Ashoo Gupta
20 Dec 2025
VP, Finance and Controller
Sold after exercise
79
$8.68
$685.72
Ashoo Gupta
20 Dec 2025
VP, Finance and Controller
Sold after exercise
310
$8.68
$2.69K
Scott Bizily
16 Dec 2025
Chief Legal Officer
Sold after exercise
1,635
$10.90
$17.82K
Charles Theuer
12 Dec 2025
Director
Exercised, kept
9,333
$1.14
$10.64K
Scott Bizily
17 Nov 2025
Chief Legal Officer
Sold after exercise
1,635
$10.59
$17.31K

What was left out

Form 4 filings counted 31
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 15
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 88,275
History held since 17 Dec 2020